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ABSTRACT
Staphylococcus epidermidis (SE) is an opportunistic pathogen capable of infecting humans and 
animals. It is a frequent cause of hospital-acquired infections in humans and intramammary 
infections (IMIs) in dairy cows. Th e aim of this study was to compare the protein expression 
profi les and the genomes of three SE strains, one associated with bovine mastitis (PM221), one 
representing a commensal/low-virulent human strain (ATCC12228 isolated from a healthy 
human host) and the third being a virulent human strain (RP62A isolated from a catheter-
associated sepsis), in order to reveal the factors employed by this species for virulence, survival 
and adaptation.
Th e genome-level analysis (I) revealed that the genome of a SE strain PM221 isolated 
from subclinical bovine IMI resembled more the commensal-type, low-virulent human strain 
ATCC12228 than the virulent human strain RP62A. While a comparative proteome analysis and 
the total proteome profi ling (I, II) confi rmed the close relationship between the bovine PM221 
and the commensal-type ATCC12228, certain strain-specifi c diff erences were found which are 
believed to have roles in adaptation and virulence. Th ese fi ndings may explain why ATCC12228 
was able to cause persistent mastitis in an experimental infection study but with a milder 
clinical outcome than encountered with the bovine strain PM221. Taken together, these fi ndings 
strengthen the hypothesis that humans could represent an important source of SE-mediated 
infections in dairy cows. 
Th e exoproteomes of the three SE strains were characterized (III) in an attempt to 
investigate the infectious potential in more details. Th is study showed that the PM221 and 
RP62A exoproteomes were more similar, diff ering from that of ATCC12228. Th e major part 
of the identifi ed exoproteins were predicted to be cytoplasmic, indicating that these proteins 
might be surface-displayed moonlighting proteins released into the culture medium via some 
yet uncharacterized mechanism, or that they had been embedded in membrane vesicles (MVs) 
that export proteins in a concentrated and protected manner. Th e results also suggest that these 
non-classical protein secretion pathways were being more effi  ciently exploited by PM221 and 
RP62A. In summary, the exoproteomic results can explain the higher virulence capacity of 
PM221 compared to ATCC12228. 
Phenotypic tests were conducted to confi rm some of the major proteomic results. 
Th ese tests indicated that SE may use several strategies to improve its adaptation to diff erent 
environments; the virulent bovine and human strains (PM221 and RP62A) were able to use 
biofi lm formation for colonization and adaptation, and PM221 and the commensal-type human 
strain (ATCC12228) could downregulate their tricarboxylic acid cycle activity and increase the 
formation of small colony variants to improve bacterial survival during the stationary phase. 
In addition, the bovine PM221 strain may possess an advantage since it has higher tributyrin 
activity in the milk environment, whereas the human strains may benefi t from their higher 
urease and/or catalase activities helping these strains to survive in their ecological niches (i.e. on 
human skin, mucous membranes) and indwelling medical devices.
In conclusion, the present studies demonstrate that the SE species may exploit diverse 
strategies involving specifi c changes in their late stationary phase metabolism as well as in 
protein export strategies accompanied by increased production of certain enzymes in  order to 
ensure better adaptation and/or successful infection. 
 
11 INTRODUCTION
1.1. SE is an opportunis? c human and animal pathogen
Th e Gram-positive bacterium Staphylococcus epidermidis (SE) is a coagulase-negative 
staphylococcus (CoNS) that is a normal habitant of human skin and mucous membranes. As a 
part of human microbiota, it has a benign relationship with the host, and it is even able to hinder 
the colonization of potentially more harmful microbes, such as Staphylococcus aureus (SA), thus 
it can be considered as a “skin probiotic” conferring protective immunity. (Cogen, Nizet et al. 
2008, Iwase, Uehara et al. 2010, Wanke, Steff en et al. 2011, Al-Mahrous, Jack et al. 2011, Naik, 
Bouladoux et al. 2012, Sugimoto, Iwamoto et al. 2013)
Despite the fact that SE is the most frequently encountered CoNS species on human skin 
and that it normally adopts a commensal lifestyle, it is also by far the most frequent source of 
infections caused by CoNS in humans (Otto 2009). Since SE is also able to infect animals (Pyörälä, 
Taponen 2009), it can be viewed as a pathogen with both medical and veterinary relevance. For 
example, it has been estimated that at least 22% of the bloodstream infections associated with 
central vascular catheters and about 13% of the prosthetic valve endocarditis infections are 
caused by SE (Otto 2009). CoNS are the predominant cause of bovine intramammary infections 
(IMIs) in several countries, and SE is one of the fi ve CoNS species (Staphylococcus chromogenes, 
Staphylococcus simulans, Staphylococcus haemolyticus, Staphylococcus xylosus, and Staphylococcus 
epidermidis) most frequently identifi ed as IMI causing species (Th orberg, Danielsson-Th am et al. 
2009, Moser, Stephan et al. 2013, Vanderhaeghen, Piepers et al. 2014). 
1.1.1 SE as a nosocomial human pathogen
SE is a major causative agent of hospital-acquired, nosocomial infections. SE infections are 
typically associated with indwelling medical devices such as heart valves, catheters and optical 
lenses especially in immunocompromised patients, newborns and elderly individuals. (von Eiff , 
Peters et al. 2002, Otto 2009, Rogers, Fey et al. 2009, Schoenfelder, Lange et al. 2010, Otto 2012) 
Th ese infections oft en cause only moderate clinical symptoms, and are seldom life-threatening, 
because SE does not produce many aggressive virulence factors, such as toxins or exoenzymes, 
or produces them only in moderate amounts (Zhang, Ren et al. 2003, Gill, Fouts et al. 2005, Otto 
2012). Nevertheless, the medical implications of nosocomial SE infections are substantial, as the 
treatment is usually diffi  cult, and the infections tend to become chronic. 
One of the reasons behind the rise of SE as a nosocomial pathogen is the extensive and 
expanding use of biomaterials in medicine, such as catheters, heart valve prostheses, orthopedic 
implants and pacemakers (Campoccia, Montanaro et al. 2013). Th ese devices are prone to SE 
colonization and infection because they off er suitable surfaces onto which SE can adhere and 
colonize. Once attached onto a surface, SE is able to form biofi lms, which are surface-attached 
bacterial communities embedded in a “sticky” extracellular matrix (Costerton, Stewart et 
al. 1999). Once this slimy bacterial biofi lm has been formed, the treatment becomes diffi  cult 
as the microbial cells within the biofi lm are well protected. An additional challenge is due to 
the fact, that SE strains are also frequently resistant to many antibiotics. (Costerton, Stewart et 
al. 1999, Gill, Fouts et al. 2005, Otto 2012, Otto 2013b, Begovic, Jovcic et al. 2013) Th e lack of 
response to medical treatments leads to persistent and chronic infections requiring removal 
of the device, which in turn may mean extra surgical operations and longer hospital stays. In 
addition, biofi lms repeatedly release bacteria into the bloodstream and other tissues, causing 
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2severe secondary infections, such as bacteremia, endocarditis and osteomyelitis, which in turn 
signifi cantly increase morbidity and mortality. (Huebner, Goldmann 1999, Mack, Davies et al. 
2007, Van Mellaert, Shahrooei et al. 2012, Fey, Olson 2010) Yet another risk associated with SE 
in hospital environments originates from the fact that SE can serve as a reservoir of antibiotic 
resistance genes to be horizontally transferred to SA, leading to the emergence of the notorious 
methicillin-resistant SA (MRSA)(Wielders, Vriens et al. 2001, Bloemendaal, Brouwer et al. 2010, 
Otto 2013a). 
As the human population is aging, the use of indwelling medical devices increases. At the 
same time, the wide-scale use of antibiotics and disinfectants is creating a favorable environment 
for the rise of resistant and well-adapted strains in hospitals. For these reasons, the number of 
diffi  cult nosocomial infections caused by SE has been predicted to continue to increase in the 
future (Schoenfelder, Lange et al. 2010, Van Mellaert, Shahrooei et al. 2012). 
1.1.2 SE as a mas? ? s causing animal pathogen
In addition to being a human pathogen, SE is also one of the major causative species of 
intramammary infections (IMI) in livestock such as dairy cattle (Taponen, Simojoki et al. 2006, 
Taponen, Koort et al. 2007, Mørk, Jørgensen et al. 2012, Taponen, Pyörälä 2009, Fitzgerald 2012, 
Pyörälä, Taponen 2009, Th orberg, Danielsson-Th am et al. 2009, Moser, Stephan et al. 2013, 
Vanderhaeghen, Piepers et al. 2014). Like human SE infections, also SE IMIs are usually only 
mildly clinical or even subclinical, but oft en persistent (Taponen, Simojoki et al. 2006, Taponen, 
Koort et al. 2007, Taponen, Pyörälä 2009, Th orberg, Danielsson-Th am et al. 2009, Zadoks, Watts 
2009, Mørk, Jørgensen et al. 2012). Unlike the situation in humans, SE is not a part of the normal 
microbiota of bovine skin or mucous membranes (Th orberg, Kuhn et al. 2006, Jaglic, Michu 
et al. 2010). Th e SE strains that have been isolated from bovine IMI share the same genotype 
with those strains that have been isolated from the milker’s skin. Th ey also seem to produce the 
same virulence factors and antimicrobial resistance patterns as the strains that are isolated from 
human infections (Th orberg, Kuhn et al. 2006, Sawant, Gillespie et al. 2009, Jaglic, Michu et al. 
2010). Th ese observations have led to the hypothesis that cows may acquire SEs from the humans 
that are working in the barn environment, i.e. humans could be the source of mastitis causing 
SEs (Th orberg, Kuhn et al. 2006, Jaglic, Michu et al. 2010, Piessens, Van Coillie et al. 2011).
Th e frequent occurrence of IMI in dairy herd results in animal suff ering, in extensive use of 
antibiotics, and in signifi cant fi nancial losses due to the veterinary costs and reductions in milk 
production. Th e large-scale use of antibiotics also raises concerns about the spread of antibiotic 
resistance and food safety (Boehmer 2011, Walther, Perreten 2007). Th is concern for antibiotic 
resistance is even more pronounced in SE than in other mastitis causing CoNSs, as the milk-
isolated SE strains exhibit greater phenotypic resistance to multiple antimicrobials than the other 
milk-isolated CoNSs (Sawant, Gillespie et al. 2009). 
1.2 The molecular basis of SE infec? ons
Th e central aspects of SE pathogenicity are the molecules and mechanisms that these bacteria 
use to interact with the surrounding environment, and its ability to survive in the host. Th e 
staphylococcal virulence factors have been broadly categorized into four factors i.e. those that 
are i) involved in adhesion and invasion, ii) mediating degradation of host cells, iii) enabling 
the bacteria to evade host immune response, and iv) involved in the utilization of host-derived 
nutrients (Hecker, Becher et al. 2010).  
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3Proteins are important for the interaction with the environment. In order to interact with the 
environment, these proteins must be exposed outside the bacterium either as attached to the cell 
wall and/or cell membrane (i.e. surfacome) or secreted out of the cell (i.e. exoproteome) as freely 
soluble proteins or encapsulated in vesicle structures. Th ese proteins have good opportunities to 
interact with the environment, and to be recognized by the host immune system and thus to act 
as antigens or immunomodulators. Th erefore they are oft en regarded as targets for new vaccines 
and diagnostic tools and in this respect they are of major medical importance. (Dreisbach, van 
Dijl et al. 2011, Olaya-Abril, Jimenez-Munguia et al. 2013) Th e virulence factor that is regarded 
as the single most important contributor in SE’s survival and pathogenicity in humans is its 
ability to form and grow as a biofi lm, a phenomenon that is also dependent on exoproteins. (Fey, 
Olson 2010, Otto 2012, Otto 2013b)
1.2.1 Cell wall/membrane-associated surface proteins and secreted proteins
Th e cell envelope that surrounds the bacterial cell serves many vital functions. For example, it 
maintains cation homeostasis, exports and imports various important ions and molecules, and 
serves as a platform for surface proteins (Scott, Barnett 2006). Th e cell envelope of Gram-positive 
bacteria consists of a cytoplasmic membrane and an outer cell wall. Th e cytoplasmic membrane 
is a phospholipid bilayer that contains integral membrane proteins (IMPs). Th e cell wall that 
surrounds the cytoplasmic membrane is a cross-linked peptidoglycan mesh containing anionic 
polymers called teichoic acids threading through the peptidoglycan layers, plus a wide variety 
of surface-attached proteins and other polymers (Figure 1). (Desvaux, Dumas et al. 2006, Scott, 
Barnett 2006, Silhavy, Kahne et al. 2010) 
Th e bacterial surface proteins are expressed extensively during the exponential growth 
phase. For example, they protect the bacteria from environmental hazards, promote nutrition 
acquisition, attach to extracellular components, undergo interactions with other bacteria and the 
host cells, carry out enzymatic activities and help with immune evasion (Scott, Barnett 2006, 
Olaya-Abril, Jimenez-Munguia et al. 2013). Th e four major types of cell surface proteins in 
Gram-positive bacteria are i) integral membrane proteins (IMPs) passing the cell membrane with 
trans-membrane domains, ii) lipoproteins that are covalently attached to the membrane lipids 
via an N-terminal lipobox that mediates covalent binding of a conserved Cys residue to a lipid, 
iii) cell-wall associated proteins that are covalently attached to the peptidoglycan wall through 
the LPXTG-anchoring motif, and iv) other proteins that bind to distinct cell wall components 
with specifi c binding domains (Figure 1). Th ese specifi c binding domains (iv) include leucine-
rich repeat region (LRR) that is involved in protein-protein and protein-ligand interactions; 
LysM is a C-terminal lysine mediating non-covalent attachment to peptidoglycan; C-terminal 
anchoring signal motifs LPXTG, NPQTN and EVPTG for sortase-mediated protein anchoring; 
and TLXTC, a sortase signature motif with a catalytic cysteine residue. (Mazmanian, Ton-Th at 
et al. 2002, Desvaux, Dumas et al. 2006, Scott, Zahner 2006, Scott, Barnett 2006, Matsushima, 
Miyashita et al. 2010).
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4Figure 1. Major types of cell surface proteins in Gram-positive bacteria: IMPs (integral 
membrane proteins) with trans-membrane domains; lipoproteins attached to the lipids via 
the lipobox; proteins that covalently attach to the cell wall through LPXTG-anchor; and other 
cell wall-attached proteins (CWBs) with distinct anchoring motifs (LysM, a C-terminal lysine 
mediating a non-covalent attachment to peptidoglycan; C-terminal sorting signal motifs 
EVPTG, NPQTN and TLXTC; LRR, a leucine-rich repeat region involved in protein-ligand 
and protein-protein interactions). Th e fi gure shows also proteins secreted out of the cell, and 
wall teichoic acids (WTAs) / lipoteichoic acids (LTAs) spanning the cell wall and attaching to 
peptidoglycan (WTAs) and membrane lipids (LTAs). 
At the time when the bacterium enters into the late exponential growth phase, the expression 
and export of proteins shift s from surface proteins towards those that are secreted into the 
extracellular milieu (Figure 1). Th ese secreted proteins also serve vital tasks in bacterial survival, 
communication between cells, response to environmental stress, and nutrient acquisition 
(Tjalsma, Antelmann et al. 2004), and they include many virulence factors, such as proteases, 
lipases, nucleases and autolysins. (Bowden, Chen et al. 2005, Otto 2012) For example, the 
secreted proteases contribute to bacterial virulence by scavenging nutrients (Dubin 2002), while 
secreted lipases are regarded as important players in the colonization of lipid-rich environments 
such as the skin, the main living niche for SE (Simons, van Kampen et al. 1998, Bowden, Visai et 
al. 2002, Powers, Smith et al. 2011). 
1.2.2 Non-classical secre? on - moonligh? ng proteins and membrane vesicles
Gram-positive bacteria use several mechanisms to secrete proteins out of the cell. Th e so-called 
classical protein secretion mechanisms include for example the general secretory (Sec) pathway 
and the twin arginine (TAT) pathway. Th e most common export system is the Sec system that 
requires the presence of an N-terminal signal sequence in the protein to be secreted. (Scott, 
Barnett 2006, Powers, Smith et al. 2011, Freudl 2013) While the classical secretion mechanisms 
have been widely studied in Gram-positive bacteria (Scott, Barnett 2006, Powers, Smith et al. 
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52011, Freudl 2013), these are not the only ways with which the bacterium can export proteins 
into the extracellular milieu. Th ere are also non-classical and much less studied secretion systems 
e.g. moonlighting proteins and membrane vesicles (MVs) (Figure 2) (Kainulainen, Korhonen 
2014, Lee, Choi et al. 2009).  
Figure 2. Non-classical secretion systems in SE. Left : Moonlighting proteins attached to the cell 
surface. Right: Protein-containing secreted membrane vesicle. (Not in scale) 
Moonlighting is a rather recently discovered aspect of bacterial exoproteome of both pathogenic 
and commensal bacteria. Proteins are said to be moonlighting when they express more than 
one function and these functions take place at diff erent cellular locations (Henderson, Martin 
2011). Th e canonical functions of these proteins are involved in central cellular functions, 
such as glycolysis, chaperone activity, protein synthesis, and stress responses, and occur in 
the cytoplasm. Th eir moonlighting functions have oft en been associated with adhesion to 
extracellular components thus contributing to host-microbe interactions, and these take place 
on the cell surface. (Pancholi, Chhatwal 2003, Carneiro, Postol et al. 2004, Xolalpa, Vallecillo 
et al. 2007, Henderson, Martin 2011, Wang, Xia et al. 2013, Kainulainen, Korhonen 2014) 
Some moonlighting proteins can also act as receptors for e.g. the complement system subunits 
and modulate host immune responses. (Agarwal, Hammerschmidt et al. 2012, Wang, Kelly et 
al. 2001, Terao, Yamaguchi et al. 2006, Bhattacharya, Ploplis et al. 2012, Henderson, Martin 
2011). In commensal bacteria, moonlighting proteins have similar functions as in pathogenic 
bacteria, such as adhesion (Antikainen, Kuparinen et al. 2007a, Kinoshita, Uchida et al. 2008, 
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6Kainulainen, Loimaranta et al. 2012), possibly helping the commensal bacteria to compete for 
receptors against pathogens and therefore they occupy the attachment sites preventing binding 
of pathogenic species (Spurbeck, Arvidson 2010). 
It is not yet known how these moonlighting proteins are secreted outside of bacterial cells. 
Th ey might be exported through some yet unknown secretion mechanism or – as they do not 
seem to have any known secretion or anchoring signals – they may be released from traumatized 
and/or lysed cells (Kainulainen, Korhonen 2014). Th ese two alternatives are not mutually 
exclusive, and there has been evidence supporting both hypothesis (Boel, Pichereau et al. 2004, 
Boel, Jin et al. 2005, Yang, Ewis et al. 2011) as well as for the hypothesis that they are released as 
a part of a cellular stress response (Eichenbaum, Green et al. 1996, Candela, Centanni et al. 2010, 
Kainulainen, Loimaranta et al. 2012). It has been suggested that the moonlighting proteins use 
ionic interactions to attach themselves to the cell surface, for example to the negatively charged 
teichoic acids (Antikainen, Kuparinen et al. 2007b, Weidenmaier, Peschel 2008, Kainulainen, 
Loimaranta et al. 2012). 
Th e release of protein containing membrane vesicles (MVs) from the bacterial surface is 
another way for the bacterium to secrete proteins that do not have a canonical secretion signal 
sequence (Bonnington, Kuehn 2014). Th e release of MVs from the cell surface is a conserved 
feature in bacteria and has been demonstrated both in vitro and in vivo. It has been known 
for decades that MVs are released from Gram-negative bacteria. Recently, evidence has also 
accumulated indicating that Gram-positive bacteria use this export mechanism as well (Lee, 
Choi et al. 2009, Gurung, Moon et al. 2011, Lee, Lee et al. 2013, Th ay, Wai et al. 2013). Natural 
MV production was found in SA a few years ago (Lee, Choi et al. 2009). Th e SA MVs share 
many features with the extensively studied outer membrane vesicles (OMVs) of Gram-negative 
bacteria; they are similarly spherical, bilayered, and closed membranous structures, albeit with 
slightly smaller diameters ranging from 20 to 100 nm (Figure 2) (Lee, Choi et al. 2008, Lee, Choi 
et al. 2009, Gurung, Moon et al. 2011). 
It has been proposed that the inclusion of proteins into MVs helps the bacteria to protect 
the proteins from extracellular proteolytic degradation, thus enhancing the long-distance protein 
delivery and ensuring an appropriate protein concentration at the target (Bonnington, Kuehn 
2014). Th e numerous functions proposed for MV-based protein secretion include adherence, 
invasion, damage to host cells, immune response modulation, biofi lm development, nutrient 
acquisition, interspecies cooperation, and protection against antibiotics and host defense 
mechanisms (Kulp, Kuehn 2010, Deatherage, Cookson 2012, Bonnington, Kuehn 2014). 
Th e MVs are known to deliver diff erent toxins, enzymes and antigens, so they are commonly 
recognized as contributors of bacterial pathogenesis (Deatherage, Cookson 2012, Lloubes, 
Bernadac et al. 2013).   
1.2.3 Persistence through biofi lm forma? on
Since SE does not produce aggressive virulence determinants, the key factor in its pathogenicity 
in human infections is its ability to form biofi lms. Th e biofi lm is a structured, high-density and 
multilayered adherent growth mode of bacteria where the micro-organisms might be attached 
to a surface and to each other, and produce a protective extracellular polymer matrix - slime 
– consisting polymers such as polysaccharides, proteins and extracellular DNA. Th is growth 
mode enables quorum sensing cell-cell communication between the bacteria, protects the 
bacteria from being washed away and defends the bacterial community against environmental 
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biofi lm-forming bacteria to survive and persist in the host both during normal colonization and 
in infectious states. (Costerton, Stewart et al. 1999, Mack, Davies et al. 2007, Otto 2008, Hoiby, 
Bjarnsholt et al. 2010) 
Th e formation of biofi lms proceeds through four stages: attachment, accumulation, 
maturation and dispersal (Figure 3) (Otto 2008, Fey, Olson 2010). Th e initial adherence to host 
matrix or biomaterial is nonspecifi c and hydrophobic in nature, but there are specifi c proteins 
called microbial surface components recognizing adhesive matrix molecules, MSCRAMMs, 
mediating this primary adhesion. Th ese include autolysins AtlE and Aae, extracellular matrix 
binding proteins Embp and lipase GehD, that bind to host components such as fi bronectin, 
fi brinogen, vitronectin and collagen. (Fey, Olson 2010, Otto 2008, Mack, Davies et al. 2007, 
Bowden, Chen et al. 2005) Furthermore, extracellular DNA (eDNA) released by SE has been 
implicated as a component contributing to the attachment phase by binding to appropriate 
surfaces such as polystyrene and glass (Qin, Ou et al. 2007).
Figure 3. Biofi lm development. Th e main phases in biofi lm development are attachment of the 
planktonic cells to the surface, bacterial accumulation, biofi lm maturation, and dispersal. Th e 
green cells represent dispersed cells that have recently been described as unique intermediate 
phase in the bacterial life cycle (Chua, Liu et al. 2014). (Figure modifi ed from: Otto, M. 
Staphylococcus epidermidis--the ‘accidental’ pathogen. Nat Rev Microbiol. 2009 Aug;7(8):555-
67) 
Th e next phase, accumulation, can be polysaccharide-, protein- and/or DNA-mediated. Th e 
polysaccharide intercellular adhesion (PIA)-mediated-biofi lm formation is the most common 
way for SE to accumulate into biofi lms, and this mechanism seems to be present in many 
disease-associated human strains (Fey, Olson 2010). PIA is encoded by the ica operon and is 
an extracellular polysaccharide mediating bacterial adherence and aggregation, contributing to 
virulence and defending the bacteria from the defenses mounted by the host. In addition to PIA, 
SE can also produce an exopolymer called poly-γ-glutamic acid (PGA), which is an essential 
compound of the biofi lm matrix and a key player in immune evasion in both commensal 
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resistance to antimicrobial peptides and phagocytosis, possibly interacting with PIA. (Mack, 
Fischer et al. 1996, Costerton, Stewart et al. 1999, Vuong, Voyich et al. 2004, Fey, Olson 2010) 
In the absence of the ica operon coding for PIA, PIA can be substituted with proteinaceous 
factors such as accumulation associated proteins Aap and biofi lm-associated proteins bap/bhp 
in the biofi lm formation, and in such situation, the biofi lm is defi ned as being protein-mediated 
(Rohde, Burdelski et al. 2005, Tormo, Knecht et al. 2005). eDNA has also been proposed to 
function as a cell-to-cell connector in the biofi lm accumulation phase of SE (Qin, Ou et al. 2007).
During the maturation phase, the bacteria shift  their physiology towards anaerobic or 
microaerobic metabolism, and downregulate the synthesis of proteins, cell wall components and 
DNA. A mature biofi lm contains bacteria that are in diff erent metabolic states: some growing 
aerobically, some anaerobically, some are dormant and some are dead cells. (Fey, Olson 2010, 
Mack, Davies et al. 2007, Mah, O’Toole 2001) Th ere are several proteins that are associated with 
biofi lm maturation, such as accumulation-associated protein (Aap) and extracellular matrix 
binding protein (Embp). Nevertheless, the secreted surfactant peptides called phenol soluble 
modulins (PSMs) are the only biofi lm maturation determinants for which there is in vivo 
evidence (Otto 2013b). In SE, PSMs and the Agr (accessory gene regulator) quorum-sensing 
system regulating the expression of PSMs have been identifi ed as key players in the biofi lm 
structuring, as well as in the fi nal development stage i.e. biofi lm detachment and dissemination 
(Wang, Khan et al. 2011, Periasamy, Joo et al. 2012, Otto 2013b). During the dispersal stage, 
individual bacterial cells can disengage from the biofi lm and metastasize (Hoiby, Bjarnsholt 
et al. 2010, Otto 2013b). Recently, it has been demonstrated that in the bacterial life cycle, the 
dispersed cells represent unique intermediates between planktonic and biofi lm lifestyles. In 
Pseudomonas aeruginosa, these dispersed cells have displayed unique phenotypes that diff ered 
from both planktonic and biofi lm cells. For example, the dispersed cells were highly sensitive 
towards iron stress and were more virulent compared with the planktonic cells. (Chua, Liu et al. 
2014) 
Th e balance between the number of bacterial cells that are in the planktonic growth 
mode and those that are in the biofi lm growth mode at a given time point is called phenotypic 
variation: a certain proportion of the population does not produce biofi lm but stays planktonic. 
Th e rationale behind this is that the presence of diverse subpopulations increases the range of 
conditions in which the community as a whole can thrive. (Handke, Conlon et al. 2004, Fey, 
Olson 2010)
Even though the importance of biofi lm formation in human nosocomial SE infections is 
currently accepted (Otto 2013b), there is no defi nite evidence that biofi lm formation of CoNS 
has a role in the clinical outcome or severity of mastitis (Simojoki, Hyvönen et al. 2012, Tremblay, 
Lamarche et al. 2013). For example, in the study of Simojoki et al. (2012), where the biofi lm-
forming ability of almost 200 CoNS isolates from bovine mastitis was investigated, no association 
was detected between the ability to form biofi lm / extracellular slime and the persistence of IMI 
or the severity of mastitis (Simojoki, Hyvönen et al. 2012). At the same time, slime production 
was found to be more common in persistent than spontaneously cured infections, and SE was 
producing slime more commonly than the other CoNS species studied. It has been hypothesized 
that even though biofi lm formation does not contribute to the severity of IMI, it could promote 
the establishment and persistence of CoNS in the mammary gland, although the results for this 
proposal are indirect and speculative (Vanderhaeghen, Piepers et al. 2014). Th is hypothesis is 
in line with studies demonstrating that the biofi lm-forming ability of SA promotes bacterial 
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treatment. Th ese qualities in turn lead to persistent, albeit milder, infections than those caused 
by biofi lm-negative strains. (Cucarella, Tormo et al. 2004, Clutterbuck, Woods et al. 2007)
1.2.4 Resistance to an? bio? cs
One of the problems in the treatment of SE infections is their resistance to many antibiotics. 
In particular, the resistance to methicillin is widespread in SE strains isolated from hospitals 
(methicillin-resistant SE, MRSE). It has been estimated that over 75% of SEs isolated from 
hospital environments around the world are resistant to methicillin, although there are extensive 
geographical variations in the frequency of resistant strains (Diekema, Pfaller et al. 2001, Stefani, 
Varaldo 2003). In addition to resistance against the widely used methicillin, there are strains that 
are resistant to several other groups of antimicrobial drugs, such as macrolides, aminoglycosides 
and tetracyclines. Th ere are also strains that are multiresistant, and new mutations can lead to the 
birth of new resistances and combinations of multiresistance. (Carbon 2000, Rogers, Fey et al. 
2009, Otto 2012) SE has also developed intermediate resistance to vancomycin, a phenomenon 
that is especially problematic because vancomycin is the most widely used antimicrobial agent to 
combat the severe infections caused by Gram-positive bacteria (Sanyal, Greenwood 1993, Jones 
2006, Rogers, Fey et al. 2009). It has been hypothesized that SE can function as a reservoir and a 
source of antibiotic resistance genes that could be horizontally transferred to the more aggressive 
pathogen SA, converting it into antibiotic resistant strain such as MRSA (Otto 2013a). Although 
antibiotic resistance has spread widely among hospital-acquired SE isolates, it is considerably less 
frequent in community-acquired SE strains (Witte, Cuny et al. 2008, Rogers, Fey et al. 2009).
In addition, the formation of biofi lm per se is an eff ective, non-specifi c mechanism of 
antibiotic resistance (Otto 2012). Th is is due to many attributes of the biofi lm. For example, the 
biofi lm matrix represents a physical and chemical barrier against penetrance for antibiotics, and 
it contains subpopulations of non-responding slow-growing and persister cells (Mah, O’Toole 
2001, Stewart 2002). Th us, it must be considered that while the planktonic bacterial cells might 
be responsive to a certain treatment, its sessile, biofi lm counterpart or the dispersed cells might 
not be treated by the same compound (Duguid, Evans et al. 1992, Van Mellaert, Shahrooei 
et al. 2012, Chua, Liu et al. 2014), which constitutes yet another obstacle in the fi ght against 
staphylococcal infections.
 
1.3 Genomic analyses of SE
Th e virulence factors of SE have been investigated by phenotypic and genotypic methods, 
but there are only a limited number of genomic studies focusing on SE strains of diff erent 
environmental origins. Prior to this study, two complete genome sequences of SE had been 
reported, namely the genomes of the low-virulent ATCC12228 isolated from a healthy human 
host (Zhang, Ren et al. 2003) and the virulent RP62A isolated from a case of catheter-associated 
sepsis (Gill, Fouts et al. 2005). 
Th e genome of ATCC12228 consists of one chromosome and six plasmids (Zhang, Ren 
et al. 2003). It has 2485 open reading frames (ORFs), and the chromosomal G+C ratio is 
32.1%. Th e ATCC12228 genome was compared with the genome of SA strain N315, and this 
comparison revealed that ATCC12228 does not possess – apart from the β- and δ-hemolysin 
genes - the exotoxin genes present in N315. Instead, it has genes for less invasive exoenzymes, 
fewer antibiotic resistance genes and it lacks the PIA-encoding ica operon. On the other hand, 
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ATCC12228 has a large repertoire of adhesin genes, which in the absence of the more aggressive 
pathogenicity determinants, can act as virulence factors in ATCC12228 when/if this strain is 
causing an opportunistic infection. Th e less invasive nature of ATCC12228, predicted from the 
genome data, has also been demonstrated in mouse and rat experimental infections. (Zhang, 
Ren et al. 2003) 
Th e virulent strain RP62A has one chromosome and one plasmid, 2526 ORFs, and the 
chromosomal G+C ratio is 32.2% (Gill, Fouts et al. 2005). Th e genome of RP62A was compared 
with four SA strains (COL, Mu50, N315, MW2) and ATCC12228. Th is comparative analysis 
revealed that there are a core set of 1,681 ORFs common to all the studied strains. Variations 
between the pathogenic and resistance capabilities arise from specifi c genome islands, and in 
addition, the gene transfer between staphylococci and low-GC-content gram-positive bacteria 
can be a source of additional virulence factors. Th e study revealed that in SE, integrated plasmids 
contain e.g. genes that encode resistance to cadmium and species-specifi c surface proteins. PSMs 
and the cap operon encoding the polyglutamate capsule has also been postulated to be potential 
virulence factors of SE. A large part of the less invasive nature of SE as compared to that of SA, 
was explained by the lack of enterotoxin, exotoxin, leukocidin, and leukotoxin coding genes. 
Th e key factors in the stronger pathogenic capacity of RP62A as compared to the low-virulent 
ATCC12228 are considered to be the presence of the PIA-encoding ica operon and the adhesion- 
and biofi lm-associated cell wall protein Bap/Bhp in RP62A, whereas these genetic elements are 
absent from the ATCC12228 genome. (Gill, Fouts et al. 2005) 
In addition to the complete genomes of ATCC12228 and RP62A, there are several published 
SE draft  genomes (Table 1). For example, the study of Conlan et al. (2012) revealed that the 
existence of the formate dehydrogenase gene (fdh) diff erentiates the commensal SE strains 
from the nosocomial strains. Th erefore, fdh could be used as a marker gene for commensalism. 
(Conlan, Mijares et al. 2012) In the study of Madhusoodan et al. (2011), an S. epidermidis 
pathogenicity island (SePI) was found for the fi rst time from a clinical SE isolate strain FRI909. 
Th is SePI encodes staphylococcal enterotoxin C3 and staphylococcal enterotoxin-like toxin L, 
which is in line with the fact that the majority of virulence factors, superantigens and toxins of 
SA are encoded by S. aureus pathogenicity islands, SaPIs (Novick, Subedi 2007). Al-Mahrous 
et al. (2011), in turn, examined the SE strain A487 and identifi ed a hemolysin-like peptide that 
exerts antibacterial activity against other Staphylococcus strains, including several MRSA strains.
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Table 1. Th e published SE draft  genomes, strains and characteristics.
Name of the strain Isolated from Characteristics Reference
ET-024 biofi lm on an 
endotracheal tube 
of a mechanically 
ventilated patient
resistant to methicillin (Vandecandelaere, 
Van Nieuwerburgh et 
al. 2014)
UC7032 cured meat heteroresistant to glycopeptide 
antibiotics




may form biofi lms, resistance 
to fl uoroquinolone and beta-
lactam antibiotics
(Zhang, Morrison et 
al. 2012)
FRI909 human source SePI in genome, produces 
enterotoxin C
(Madhusoodanan, 
Seo et al. 2011)
A487 human source Inhibitory activity against 
MRSA
(Al-Mahrous, Jack et 
al. 2011)
CSUR P278 native-aortic-valve 
endocarditis







































between commensal isolates; 
nosocomial isolates exhibited 
large-scale rearrangements and 
single-nucleotide variation




MC19, Scl19, Scl25, 
CIM37, CIM28, 
WI05, WI09    
11 strains from 
wild mice
83.6% to 92.2% of the proteins 
have homologs in ATCC12228 
and/or RP62A genomes




Th ese genomic studies provide some hypotheses about the mechanisms by which SE can be 
transformed from a commensal inhabitant to an invasive pathogen, but nonetheless proteome-
level information is required in order to confi rm and complement these hypotheses.
1.4 Proteomic analyses of SE
Th e proteome is the whole set of proteins that are synthetized by a given cell under certain 
conditions at a particular time point. Th e term proteomics refers to a set of technologies that are 
used for the analysis of proteomes, including protein identifi cations, modifi cations, localizations, 
dynamics and abundances. It is a group of high-throughput methods that are largely based 
on the use of mass spectrometry (MS) for the identifi cation and quantitation of proteins and 
modifi cations. Previously, 2-DE (two-dimensional gel electrophoresis) was most oft en considered 
to be the method of choice in proteomics. In 2-DE, the fi rst dimension of protein separation 
is isoelectric focusing (IEF) where the proteins are separated based on their isoelectric points 
(pIs), and the second dimension is SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel 
electrophoresis) which additionally separates the proteins according to their molecular weights 
(MWs). Th e resulting two-dimensional gel is visualized and the protein spots of interest can 
be cut out and identifi ed by MS. Recently, proteomics has moved away from the use of 2-DE 
towards the application of 1-DE (SDS-PAGE) separation methods and in-liquid-digestion prior 
to LC-MS/MS (liquid chromatography combined with tandem mass spectrometry) analysis, and 
this combination is now the most popular method in proteomics (Tyers, Mann 2003, Walther, 
Mann 2010, Lamond, Uhlen et al. 2012). 
Th e general work-fl ow of LC-MS/MS-based proteomics consists of i) sample preparation 
(e.g. organelle fractionation, labelling, gel-based protein separation etc.), ii) proteolytic protein 
digestion, iii) separation and ionization of the proteolytic peptides by LC and electrospray 
ionization (ESI), respectively, iv) analysis of the ionized peptides with MS, v) fragmentation 
of the selected peptides and the analysis of the fragments with MS/MS, and vi) data-analysis, 
including identifi cation and possible quantifi cation as well as bioinformatic analysis (Figure 4) 
(Walther, Mann 2010).  
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Figure 4. Th e general work-fl ow of LC-MS/MS-based proteomics. Th e main stages are sample 
preparation, proteolytic protein digestion, separation and ionization of the proteolytic peptides, 
MS- and MS/MS-analysis, and data-analysis.
Although SE is a signifi cant nosocomial micro-organism as well as a bovine pathogen, there are 
only few proteomic studies of SE, and most of these studies have been 2-DE -based applications 
(Table 2). Even though 2-DE is useful for visualizing metabolic pathways and responses to 
diff erent stimuli, it does have its limitations for example in detecting the hydrophobic IMPs and 
low abundant proteins (Hecker, Antelmann et al. 2008). Th ese proteomic studies have mostly 
targeted specifi c phenomena or specifi c proteome fractions instead of providing a comprehensive 
proteomic overview or profi ling. Th ey have tended to focus on the eff ects of growth phase and 
quorum-sensing system mutations on the proteome (Batzilla, Rachid et al. 2006), on the eff ect of 
diff erent concentrations of an SPase inhibitor on the stationary-phase secretome (Powers, Smith 
et al. 2011), on the immunoreactive or serum binding cell wall-associated proteins (Sellman, 
Howell et al. 2005), and on the diff erences between an invasive (RP62A) and a commensal 
(ATCC12228) SE strain (Yang, Li et al. 2006). Th e last-mentioned study resulted in the generation 
of 2D-gel reference maps of these two strains, but since the study focused on the diff erentially 










































































































































































































































































































































































































































































































Batzilla et al. (Batzilla, Rachid et al. 2006) investigated how a mutation in the quorum-
sensing accessory gene regulatory system (Agr) could aff ect protein synthesis. Th is group used 
2-DE with Coomassie staining (extracellular proteins) and DIGE labelling (cytoplasmic proteins) 
combined with MALDI-TOF/MS (matrix-assisted laser desorption/ionization – time-of-fl ight 
mass spectrometry) to compare the extracellular and cytoplasmic proteins of SE strains 567 (wild 
type) and 567-1 (agr mutant). Th eir results revealed that both the Agr system and the growth 
phase could aff ect the expression of surface proteins, with 14 of these diff erentially expressed 
proteins being identifi ed. Th e agr mutant expressed signifi cantly reduced amounts of several 
extracellular proteins, such as serine proteases SspA, autolysin AtlE, lipase GehD and phenol 
soluble modulins. Th ey identifi ed 51 proteins from the cytoplasmic fraction, and observed that 
the inactivated agr led to a number of alterations in the regulation of virulence as well as in the 
metabolism of amino acids and carbohydrates. (Batzilla, Rachid et al. 2006)
In the study of Powers et al. (Powers, Smith et al. 2011), the focus was on the type I signal 
peptidase and protein secretion in SE. Th e Sec-based protein export system was blocked with 
diff erent concentrations of arylomycin C16, an SPase inhibitor, in strain RP62A during its 
stationary growth phase. Th ey utilized a combination of 2DE and LC-MS/MS, and identifi ed 
11 proteins with decreased secretion i.e. that were dependent on SPase activity. Nine of these 
proteins had a canonical N-terminal SPase recognition site but the remaining two did not 
possess this sequence. Th e nine proteins with the canonical recognition site included autolysin 
AltE, immunodominant staphylococcal antigen IsaA, serine protease SspA, cysteine protease 
SspB, and secreted lipases GehC and GehD. Th e two proteins with a non-canonical recognition 
site were lipoteichoic acid synthase LtaS and a transmembrane protein BlaR1, a component of a 
two-component response regulator involved in the sensing of β-lactam antibiotics (Kobayashi, 
Zhu et al. 1987). (Powers, Smith et al. 2011)
Sellman et al. (Sellman, Howell et al. 2005) focused on the bacterial proteins that are 
expressed upon transition into the bloodstream as well as on the proteins that interact with the 
host. Th e bacteria were grown in serum to mimic the environment of the bloodstream. Th e cell 
wall-associated proteins were isolated, separated with 2-DE, and transferred to nitrocellulose 
membranes. Th e proteins were then analyzed for reactivity with sera derived from rabbits that 
had been immunized with live SE and with biotin-labelled serum proteins eluted from the 
surface of bacteria grown in rabbit serum. Th e group identifi ed 29 immunoreactive or serum 
binding proteins. Twenty-seven of these proteins were expressed in E. coli, and these recombinant 
proteins were then used to immunize mice by vaccination. Five of the recombinant proteins 
induced a statistically signifi cant reduction in the numbers of bacteria recovered from the spleen 
or bloodstream of the infected mice. Th ese were Na+/H+ antiporter, alanine dehydrogenase, 
acetyl-CoA acetyltransferase, lipoate ligase and cysteine synthase, and they were considered as 
candidate vaccine antigens. (Sellman, Howell et al. 2005)
Yang et al. (Yang, Li et al. 2006) conducted a comparative proteomic analysis of two SE 
strains, the invasive strain RP62A and the commensal strain ATCC12228 using 2DE and MS 
in an attempt to unravel the key proteins in pathogenicity. Th e overall proteome maps were 
similar in both strains, but there were 168 proteins spots exhibiting diff erential expressions 
and almost all (155) of these could be identifi ed. Th e diff erentially expressed proteins were 
involved in carbohydrate metabolism, sugar binding, lipid degradation and amino acid binding. 
Furthermore, the levels of accumulation-associated protein (Aap), an important protein in 
biofi lm formation, were lower in the non-biofi lm forming ATCC12228 in comparison to the 
concentrations in the biofi lm forming RP62A. (Yang, Li et al. 2006)
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2 AIMS OF THE STUDY
Staphylococcus epidermidis is a major nosocomial and mastitis-causing bacterium with signifi cant 
medical and veterinary relevance. Th e aim of this study was to create proteomic profi les of three 
strains of SE, one representing a low-virulent, one a virulent and the third being an animal strain 
(ATCC12228, RP62A and PM221, respectively), to identify the factors that diff erentiate the 
commensal lifestyle from its pathogenic counterpart, and to reveal the mechanisms behind SE’s 
virulence, survival and adaptation.
Th e more detailed aims were:
• To sequence the entire genome of the bovine mastitis associated strain (PM221) and to 
compare its genome sequence with those of the published SE genomes (I) 
• To study the protein expression dynamics in the logarithmic and stationary growth 
phases of PM221, ATCC12228 and RP62A (I)
• To characterize the expressed total proteomes (II) and surfacomes (I) of PM221 and 
ATCC12228, and the exoproteomes (III) of PM221, ATCC12228 and RP62A
• To complement the genome and proteome fi ndings by using an in vivo infection model 
(I)
Aims of the study
17
3 MATERIALS AND METHODS
3.1  SE strains (I, II, III)
Th e SE strains used in the genome- and proteome-level analysis were PM221, a strain causing 
bovine mastitis isolated from a persistent IMI (Taponen, Koort et al. 2007), and two human SE 
strains, non-biofi lm-forming ATCC12228 (Zhang, Ren et al. 2003) with low infectious potential 
isolated from a healthy human host, and a biofi lm-positive, multi-resistant RP62A (Gill, Fouts 
et al. 2005) that is able to cause chronic human infections and which had been isolated from 
catheter-associated sepsis. 
3.2 Genome sequencing, assembly and annota? on (I)
Genomic and plasmid DNAs of PM221 were extracted from planktonic cultures. Th e genome 
of PM221 was sequenced, and the reads were assembled into contigs, most of them mapped 
to the genome of ATCC12228, and the gaps were closed. Protein coding sequences were 
predicted with Glimmer and RAST (Rapid Annotation using Subsystem Technology), and the 
automated annotations obtained by RAST were manually adjusted based on information from 
diff erent databases (e.g. KEGG, TIGR, Prosite and InterPro and COG) Prophages, whole-
genome nucleotide alignments, IS elements and RNA genes were predicted using several tools 
(Prophinder. BLAST, RAST). 
3.3 Genome and gene comparisons (I)
Orthologs and in-paralogs among the genes of PM221, ATCC12228 and RP62A were identifi ed 
using two complementary tools (BLASTP, OrthoMCL) and on the basis of protein sequences 
from 36 genomes of interest. Nine diff erent species were used in the genome comparison: SE, 
SA, Staphylococcus capitis, Staphylococcus carnosus, Staphylococcus haemolyticus, Staphylococcus 
hominis, Staphylococcus lugdunensis, Staphylococcus saprophyticus, and Staphylococcus warneri 
(Table 3). Th e phylogenetic tree was constructed using OrthoMCL, Muscle, GBLOCKS and 
PhyML. Th e whole genome and plasmid sequences of PM221 were compared with the published 
genome sequences of ATCC12228 and RP62A.
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Table 3. Th e Staphylococcus strains used in the pan-genome analysis. Protein sequences were downloaded 
from ft p://ft p.ncbi.nlm.nih.gov/ genomes/Bacteria/
Strains
Staphylococcus epidermidis ATCC12228 Staphylococcus aureus Mu3
Staphylococcus epidermidis BCM-HMP0060 Staphylococcus aureus Mu50
Staphylococcus epidermidis M23864:W1 Staphylococcus aureus MW2
Staphylococcus epidermidis M23864:W2 Staphylococcus aureus N315
Staphylococcus epidermidis PM221 Staphylococcus aureus NCTC 8325
Staphylococcus epidermidis RP62A Staphylococcus aureus Newman
Staphylococcus epidermidis SK135 Staphylococcus aureus RF122
Staphylococcus epidermidis W23144 Staphylococcus aureus ST398
Staphylococcus aureus 04-02981 Staphylococcus aureus TW20
Staphylococcus aureus aureus MRSA252 Staphylococcus aureus USA300 FPR3757
Staphylococcus aureus aureus MSSA476 Staphylococcus aureus USA300 TCH1516
Staphylococcus aureus COL Staphylococcus capitis SK14
Staphylococcus aureus ED133 Staphylococcus carnosus TM300
Staphylococcus aureus ED98 Staphylococcus haemolyticus JCSC1435 
Staphylococcus aureus JH1 Staphylococcus hominis SK119
Staphylococcus aureus JH9 Staphylococcus lugdunensis HKU09-01
Staphylococcus aureus JKD6008 Staphylococcus saprophyticus ATCC 15305
Staphylococcus aureus JKD6159 Staphylococcus warneri L37603
3.4 Experimental infec? on (I)
One udder quarter of two dairy cows was infected with ATCC12228, with another udder quarter 
being used as a control. Milk samples and clinical data were collected for two weeks, and bacterial 
counts, somatic cell counts (SCC), and milk N-acetyl-β-D-glucosaminidase (NAGase) activity in 
the milk were determined. Also the local and systemic clinical signs were also recorded. 
3.5 Growth phases and proteome subfrac? ons (I, II, III)
Th e bacterial cells were withdrawn from growth phases ranging from the mid-exponential to 
post-exponential stages (Table 4) since it is known that the production of virulence factors is 




Table 4. Bacterial growth stages from which the proteins samples were derived and the proteomic sub 
fractions collected and analyzed. 
  I II III
  2D DIGE Surfacome shaving Total 
proteome
Exoproteome
Th e phase 
during which 
the cells were 
collected
mid-exponential 

















whole cells trypsin-digested surfacome 
proteins
whole cells supernatants
3.6 Proteomic work-fl ow – protein and pep? de separa? on, analysis and 
iden? fi ca? on (I, II, III)
In the 2D DIGE analysis of the total proteomes of PM221, ATCC12228 and RP62A (I), the 
extracted and purifi ed proteins were labelled with Cy2, Cy3, or Cy5 dyes. Th e labeled proteins 
were fi rst separated using IEF, and then with SDS-PAGE. Th e gel images were analyzed with the 
DeCyder 2D 7.0 soft ware, and the statistical analyses showed strain and growth-stage specifi c 
changes in protein abundances. Th e selected spots fulfi lling the chosen criteria for diff erent 
abundances were cut out for in-gel digestion with trypsin followed by LC-MS/MS identifi cation 
using Ultimate 3000 nano-LC and QSTAR Elite hybrid quadrupole TOF mass spectrometer with 
nano-ESI ionization. 
In the analysis of the surfacome proteins of PM221 and ATCC12228 (I), the surface-attached 
proteins were released by trypsin-shaving from intact living cells. Th e trypsin-digested peptides 
were purifi ed with ZipTips (C18), and the tryptic peptides were identifi ed using LC-MS/MS.  
Th e extracted and purifi ed protein samples from the whole cell lysate and supernatant in 
the total proteome cataloging (II) and exoproteome cataloging (III), respectively, were analyzed 
with GeLC-MS/MS (protein separation with one-dimensional gel electrophoresis coupled with 
protein identifi cation with liquid chromatography – tandem mass spectrometry). First, the 
proteins were separated with SDS-PAGE, the gel lanes were sliced into fractions, and the proteins 
were reduced, alkylated and in-gel digested with trypsin. Th e resulting tryptic peptides were 
extracted from the gel, and analyzed with LC-MS/MS. 
Th e acquired MS/MS data were search against in-house databases with two search engines – 
Mascot and Paragon – except for the experiment with 2D DIGE analysis (I), where only Mascot 
was used. Th e in-house databases were composed of the open reading frame sets (ORFs) of 
PM221 (2530 entries), ATCC12228 (2485 entries) and RP62A (2526 entries). Th e Compid tool 
(Lietzen, Natri et al. 2010) was used to parse signifi cant hits from Mascot and Paragon searches. 
Materials and methods
20
3.7 Computa? onal proteome analyses (I, III)
Several prediction algorithms were used to characterize the proteins of the three studied SE 
strains. Th ese algorithms were used to acquire several parameters e.g. theoretical molecular 
weights (MW), isoelectric points (pI), GRAVY values (grand average hydropathy), cellular 
locations, GO (gene ontology) annotations, and COG (clusters of orthologous groups) categories 
of proteins, as well as the presence of potential signal sequences, transmembrane domains, 
lipoboxes, and cell wall anchor motifs. 
3.8 Phenotypic analyses (I, II, III)
Th e catalase activity was measured by mixing cell samples with Triton X-100 and hydrogen 
peroxide. Aft er mixing and incubation, the height of the O2-forming foam, refl ecting the catalase 
activity in the test tube, was visually compared. A detailed description of the method is presented 
in study I.
Th e tendency to form small colony variants (SCVs) was tested in a plating assay. Th e three 
SE strains were cultured for 24 h, 36 h and 48 h in tryptic soy broth (TSB). Th e cell samples 
withdrawn at the three time points and then serially diluted and plated. Th e plates were incubated 
at 37°C under aerobic conditions to obtain colonies, and the sizes and morphologies of these 
colonies were visually assessed (I).
Th e ability of PM221 to grow as biofi lm was tested by evaluating protein- and DNA-mediated 
adherent growth. ATCC12228 was used as non-biofi lm- and RP62A as biofi lm-forming controls. 
Th e strains were grown on a polystyrene support, and the protein-mediated adherent growth 
was tested using Proteinase K, whereas the DNA-mediated adherent growth was assessed using 
DNaseI. Th e absorbance of the crystal violet stained biofi lms were measured at 590 nm with a 
PerkinElmer Victor3 multilabel microtiter plate reader (II). 
Th e lipolytic activity was estimated with the tributyrin plate assay, where the tributyrin agar 
plate shows a zone of triglyceride hydrolysis due to esterase/lipase activity of the bacteria (II). 
Th e β-lactamase activity of culture supernatants was tested by using β-lactamase susceptible 
nitrocefi n as the substrate, and the urease activity was evaluated by using urea as the substrate. 
Th e hydrolysis of both substrates was monitored aft er 20 h of incubation at 37 °C at 560 nm 
(Ure) and 490 nm (Bla) (III).
3.9 Enrichment of membrane frac? on
Th e membrane vesicle fraction was enriched from the culture media by ultrafi ltration with 100 
kDa cut-off  membrane units. Th e protein composition of culture media, fl ow-throughs and 




Th is study was designed to answer the need for comprehensive genome- and proteome-level data 
from SE in order to identify the factors that would diff erentiate a commensal lifestyle from its 
pathogenic counterpart, as well as the mechanisms behind SE’s virulence, survival and adaptation. 
Th ree SE strains were studied: the recently isolated IMI causing bovine strain PM221 (Taponen, 
Koort et al. 2007), the human strain ATCC12228 with a low infection potential (Zhang, Ren et al. 
2003), and the sepsis-associated virulent human strain RP62A (Gill, Fouts et al. 2005). 
4.1 Genome-level and total proteome analyses revealed the similarity 
between PM221 and ATCC12228 (I, II)
Th e PM221 genome comprises a single 2490012 bp long circular chromosome (GC content = 32 
%), that encodes for 2393 proteins. It has additionally four plasmids that encode 116 proteins. 
Th e genome-level profi ling and comparison between PM221, ATCC122228 and RP62A (I) 
revealed that PM221 and ATCC12228 are very similar (I/Fig. 1); the overall gene organization of 
PM221 resembles more ATCC12228 than that of RP62A, and the phylogenetic analysis showed 
that the bovine strain is also evolutionary closer to ATCC12228 than to RP62A. One distinct 
diff erence noted between PM221 and the human strains was the high number (almost 600) of 
genes with paralogues as compared to the two human strains (286 and 252 genes with paralogues 
in ATCC12228 and RP62A, respectively). 
Th e PM221 genome has characteristics associated with a commensal lifestyle, for example 
it possesses the formate dehydrogenase, fdh, a marker gene for commensalism (Conlan, Mijares 
et al. 2012), and it lacks the clustered regularly interspaced short palindromic repeat (CRISPR) 
element that is thought to confer resistance against phages (Barrangou, Fremaux et al. 2007). Th e 
lack of the CRISPR element has presumably promoted the acquisition of prophage-like elements 
and specifi c genes coding for phage proteins, and one of the prophage elements was integrated 
into a genomic island encoding two superantigens. Arginine catabolic mobile element (ACME) 
that is recognized as a putative pathogenicity island and an important virulence factor in some 
non-biofi lm-producing SE strains (Diep, Stone et al. 2008) was identifi ed only in the PM221 
and ATCC12228 genomes. Th e genome of PM221 harbors also other pathogenic attributes such 
as proteases, lipases and hemolysins. One of the proteins associated with biofi lm formation, 
the accumulation associated protein (Aap), was located in a plasmid in PM221 whereas it was 
chromosomally located in the human strains.
Th e genetic resemblance of PM221 and ATCC12228 was further confi rmed in a whole-
genome comparison (unpublished data) conducted with 36 Staphylococcus genomes using 
two orthologue prediction tools, OrthoMCL and RBBH. Th is comparison revealed that of all 
the strains studied (8 strains of SE, 21 strains of SA, and S. capitis, S. carnosus, S. haemolyticus, 
S. hominis, S. lugdunensis, S. saprophyticus, and S. warneri, one strain of each) the genome of 
PM221 most resembled the genome of ATCC12228 (Figure 5), and the genomes of these two 
strains shared 2233 genes with each other. According to the RBBH analysis that utilizes more 
stringent criteria for unique genes than OrthoMCL, there were 1274 conserved genes that were 
found in each of the 36 studied genomes. Th ere were 172 genes that were common to all eight 
SE strains, but not found in the shared genomes of the SA strains or the shared genomes of other 
CoNS strains. Additionally, SE shares more genes with SA (239) than with other CoNSs strains 
studied (180). Th e preliminary analysis suggested that genes shared by all SE and SA strains, 
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but not all CoNS strains, include a high number of genes for transporter proteins, whereas 
SE strains and CoNS strains tend to share genes for DNA- and ribosome-associated proteins. 
Th e SE-specifi c genes common to all the studied SE strains include genes coding for capsule 
biosynthesis-associated proteins, resistance-related proteins and transcriptional proteins. 
When the SE genomes were compared with each other, there was a total of 1865 conserved 
genes in all eight SE strains whereas the number of genes found only in PM221 was 151. Th e 
genes that were found only from the genome of PM221 included several phage-related genes, 
truncated transposases and integrases.
Figure 5. On the left : Pan-genome comparison of 36 Staphylococcus genomes. On the right: 
Comparison of the genomes of eight SE strains (PM221, SK 135, W23144, ATCC12228, BCM-
HMP006, M23864:W1, M23864:W2, RP62A). Th e numbers of conserved and unique genes 
are indicated. Th e orthologue prediction tools used were OrthoMCL (the two upper Venn 
diagrams) and RBBH (the two lower Venn diagrams). 
4.2 Over 50% of the predicted proteome could be iden? fi ed (I, II, III)
Despite of the genetic similarity between PM221 and ATCC12228, these two strains exhibit 
diff erent phenotypes (e.g. biofi lm-formation, diff erent infection potentials, and adaptation to 
diff erent environmental niches). Proteomic approaches were used to unravel these diff erences 
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and to identify the factors that would diff erentiate a mildly infectious lifestyle (PM221) from 
the non-infectious lifestyle (ATCC12228) as well as distinguishing from the infectious lifestyle 
(RP62A).
In the proteomic analyses, all proteomic subfractions that can be isolated from Gram-
positive bacteria were covered; cytosolic proteome (I and II), membrane- and cell wall-associated 
proteins (I and II), and exoproteome i.e. secreted proteins (III) (Figure 6). 
Figure 6. Sub-proteomic fractions that were covered in the three proteomic studies (I, II, III).
Th e proteomic analyses were i) the comparative analysis of the three SE strains (PM221, 
ATCC12228 and RP62A) using 2D DIGE (I), ii) the cell-surface shaving proteomics of PM221 
and ATCC12228 (I), iii) the GeLC-MS/MS analysis for a global proteome profi ling and 
comparative proteome analysis of PM221 and ATCC12228 (II), and iv) GeLC-MS/MS analysis 
of the exoproteomes of PM221, ATCC12228 and RP62A (III) (Figure 7). 
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Figure 7. Th e work-fl ows of the three proteomic studies (I, II, III).
In the total proteome cataloging (II) done by using GeLC-MS/MS, it was possible to identify 
1400 and 1287 proteins from PM221 and ATCC12228, respectively, accounting for over 50% 
of the predicted proteomes. Since only around 50-80% of the bacterial genome is expressed 
under specifi c condition and growth phase (Hecker, Antelmann et al. 2008), the coverage of the 
expressed proteome exceeds well over 50%, representing the fi rst extensive proteome survey 




Almost 1200 of the identifi ed proteins were identifi ed from both strains, e.g. they were 
strain-shared identifi cations. In addition to these proteins, there were 200 (PM221) and 74 
(ATCC12228) identifi ed proteins that had a genetic equivalent in both strains but were identifi ed 
only from one strain, e.g. they were strain-specifi c identifi cations. Although these two strains 
are genetically very similar, there were 289 (PM221) and 260 (ATCC12228) unique genes that 
were not found in the other strains genome, and it was possible to identify 39 (PM221) and 
42 (ATCC12228) of these unique proteins. More surface-associated proteins could be identifi ed 
from PM221 than from ATCC12228, accounting for over 30% of the predicted surfacome. 
In contrast, in the trypsin shaving experiment more surfacome proteins were identifi ed 
from ATCC12228 than from PM221. In the exoproteome analysis, over 330 of the identifi ed 
exoproteins were identifi ed from all three strains, whereas the numbers of unique and strain-
specifi c identifi cations were 48, 22, and 98 in PM221, ATCC12228 and RP62A, respectively. 
Taken together (I, II, III), by using diff erent proteomic approaches, it was possible to identify 
a total of 1433 proteins from PM221 and 1328 proteins from ATCC12228 (Figure 8). Th e 33 
proteins identifi ed from PM221 in surfacome shaving (I) and exoproteome characterization 
(III) included virulence-associated proteins such as Geh2-lipase, a metalloproteinase precursor 
SepA, and  cell-wall anchored protein SesC that were not identifi ed in the total proteome study. 
Th e total of 41 proteins identifi ed from ATCC12228 in surfacome shaving and exoproteome 
characterization included adhesion- and resistance-promoting proteins such as penicillin 
binding protein 4, fi brinogen-binding protein SdrG, surface protein SesH, TcaA protein which 
is involved in glycopeptide resistance, elastase binding SepA, SesC, and fi brinogen-binding SdrF.
Figure 8. Th e number of proteins identifi ed from PM221 and ATCC12228 in total. Th e Venn 
diagrams display the number of unique and shared identifi cations from the surfacome shaving 
experiment (I), total proteome cataloging (II) and exoproteome characterization (III). 
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4.3 The protein expression profi les of PM221 and ATCC12228 are more 
alike while RP62A displays more virulence-related a? ributes (I)
Th e total proteome dynamics of the three strains were studied with 2D DIGE based proteomics 
(I). In this experiment, protein samples from logarithmic and stationary growth phase cell 
lysates were purifi ed, labelled with fl uorescent dyes, separated with 2DE and visualized. Th e data 
generated by DeCyder analysis was further investigated with statistical techniques (Principal 
Component Analysis, PCA and Hierarchical Clustering Analysis, HCA) which revealed that the 
protein expression patterns of PM221 and ATCC12228 in both growth phases clustered close to 
each other, whereas RP62A formed a separate cluster. Th is indicates that the protein expression 
profi les of PM221 and ATCC12228 are very similar whereas RP62A diff ers extensively from 
these two strains. 
Th e protein spots that showed statistically signifi cant diff erences in relative abundances 
were examined. A total of 119 protein spots displayed at least 1.3-fold change (p < 0.05) in at least 
one of the conditions tested (strain and/or growth stage), and these spots were identifi ed. Th ey 
included a number of regulators and potential virulence factors. RP62A was found to produce 
more virulence associated proteins than PM221 and ATCC12228. For example, CodY which is 
a regulator contributing to virulence and stationary phase adaptation (Sonenshein 2005, Pohl, 
Francois et al. 2009), was down-regulated in the less virulent strains (PM221 and ATCC12228) 
in the stationary phase, while its expression was unaff ected in both growth phases in RP62A. 
In addition, the ribosome-associated chaperone, the trigger factor TF, that has been shown to 
regulate major virulence factors in Gram-positive bacteria (Wu, Zhao et al. 2011), was constantly 
produced by RP62A, whereas in the other two strains the relative abundance of this factor was 
clearly reduced in stationary phase cells. With respect to the major virulence factors, more of 
the α- and β-subunits of urease (Ure) (Burne, Chen 2000) were produced in both human strains 
(ATCC12228 and RP62A) than in PM221. On the other hand, catalase which is an enzyme 
helping the bacterium to combat oxidative stress, in niche competition on nasal mucosa and 
in intracellular survival of SA (Park, Nizet et al. 2008, Das, Bishayi 2009), was more extensively 
produced in both growth phases in ATCC12228 compared to PM221 and RP62A, and this could 
be confi rmed in an in vitro catalase activity assay. 
4.4 PM221 and ATCC12228 coordinate TCA cycle and SCV forma? on in 
similar ways (I)
In addition to the diff erences in the expression of virulence-related proteins, there were also 
diff erences in the expression of proteins that are involved in the tricarboxylic acid (TCA) cycle 
and in bacterial survival during late stationary phases of growth. Th ese proteins included the 
molecular chaperone ClpC ATPase, pyruvate oxidase CidC and catabolite control protein 
A (CcpA) (Patton, Rice et al. 2005, Chatterjee, Schmitt et al. 2009, Sadykov, Hartmann et al. 
2011), which were less abundant in the stationary phase cells of PM221 and ATCC12228 in 
comparison with RP62A in the same growth phase. In addition, stationary phase PM221 and 
ATCC12228 cells exhibited a reduced abundance of proteins associated with nucleotide/
nucleoside metabolism, e.g. thymidylate synthesis. Since the formation of small colony variants 
(SCVs) that survive extremely well in the stationary phase, is associated with reduced TCA cycle 
activity and defi ciencies in thymidylate synthesis (Chatterjee, Herrmann et al. 2007, Chatterjee, 
Kriegeskorte et al. 2008), it was investigated whether these diff erences in protein productions 
would be refl ected in colony formation. Th e serially diluted cell suspensions of all three strains 
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were cultured on solid media for diff erent time periods. While the RP62A cells continued to 
form uniformly sized large colonies throughout the observation period, PM221 and ATCC12228 
started to produce colonies with diff erent sizes already aft er 24h on the solid media. When the 
culturing continued for a longer period (36h), the proportion of small-sized colonies increased 
in PM221 and ATCC12228 platings. With regard to viability, the PM221 cells started to undergo 
lysis at 48h and ATCC12228 aft er 60h while RP62A cells were still viable aft er that time point. 
Previously, PM221 has been shown to induce persistent clinical mastitis (Simojoki, Salomäki 
et al. 2011). As the genome- and proteome-level fi ndings revealed a high similarity between 
PM221 and ATCC12228, the infectious potential of ATCC12228 was tested in an experimental 
infection (I). Th e results suggest that ATCC12228 is able to evoke a persistent mastitis in cows, 
but the course of the disease and the infl ammatory reaction in the udder would be milder as 
compared to the IMI caused by PM221. For example, ATCC12228 infection did not cause any 
systemic clinical signs such as fever, and there were no changes in the appearance of milk.  
4.5 PM221 is able to form a biofi lm and exhibits higher lipoly? c ac? vity 
than ATCC12228 (II)
When the proteome catalogs of PM221 and ATCC12228 (II) were compared, several diff erences 
emerged among the surface-bound/secreted proteins. PM221 produced more identifi able 
proteins involved in biofi lm formation, drug resistance, adhesion and immune evasion, whereas 
ATCC12228 was more effi  cient in synthesizing a 67 kDa myosin cross-reactive antigen, heavy-
metal resistance proteins, and serine- and cysteine-type proteases SspA and SspB, each associated 
with virulence. As the proteins that PM221 produced in higher amounts included Aap, Aae, 
SdrE and FbpA, which are known to promote protein and/or DNA-mediated biofi lm growth 
(Rohde, Burdelski et al. 2005, Liduma, Tracevska et al. 2012, Heilmann, Th umm et al. 2003, 
Sharp, Echague et al. 2012, Merino, Toledo-Arana et al. 2009, Sugimoto, Iwamoto et al. 2013, 
Yan, Zhang et al. 2014), the protein- and DNA-mediated biofi lm formation was tested with both 
strains. As staphylococci are encountering changing environments during infections, the ability 
of SE strains to grow a biofi lm was initially tested in several conditions (unpublished data). Th ese 
preliminary tests revealed that the biofi lm forming activity of PM221 was maximal with low 
levels of CO2, and therefore a low-CO2 condition was chosen for the adherent growth test. Th e 
test revealed that PM221 was capable of adherent growth on a polystyrene support, even though 
PM221 does not have the ica operon genes encoding PIA/PNAG, that oft en mediates biofi lm 
formation (I). 
Comparison of all identifi ed proteins from PM221 and ATCC12228 (II) suggested that 
PM221 was more effi  cient in producing lipases. A tributyrin cleavage test was performed to 
determine whether this activity could be detected in vitro. In this test, PM221 was slightly more 
effi  cient in cleaving tributyrin, a natural component of milk fat, suggesting that the bovine strain 
could benefi t from this activity when living in milk. On the other hand, ATCC12228 produced 
more identifi able Geh-type lipases known to contribute to colonization and persistence on skin, 
the normal niche for this strain (Longshaw, Farrell et al. 2000, Bowden, Visai et al. 2002). In 
addition, ATCC12228 was more effi  cient in producing 67 kDa myosin cross-reactive antigen, 
heavy-metal resistance proteins, and serine- and cysteine-type proteases SspA and SspB, which 
have been associated with SE virulence.
Results
28
4.6 Trypsin shaving releases more surfacome proteins from ATCC12228 
than from PM221 (I)
In a previous experimental infection study (Simojoki, Salomäki et al. 2011), both PM221 
and ATCC12228 were found to be able to cause IMI in cows, but the clinical outcome of the 
ATCC12228 infection was milder than that caused by PM221. It was decided to examine which 
cell-surface proteins could contribute to this phenomenon by elucidating the cell-surface 
proteins of these two strains (I). Th e cells were grown in two diff ering conditions, aerobic (A) 
and microaerophilic (M), mimicking environments with high- and low-levels of oxygen as 
encountered during an infection. Th e cell-surface proteins were enzymatically released from 
the cell surface with trypsin, and analyzed with LC-MS/MS. In both conditions, ATCC12228 
produced more identifi able proteins than PM221. Th e proteins identifi ed exclusively in or with 
markedly higher identifi cation scores in PM221 included accumulation associated protein Aap, 
immunodominant antigen B (IsaB) and adhesin SdrE, all promoting bacterial adhesion and 
immunomodulatory functions (Macintosh, Brittan et al. 2009, Mackey-Lawrence, Potter et al. 
2009, Sharp, Echague et al. 2012, Yan, Zhang et al. 2014), whereas proteins more or specifi cally 
produced by ATCC12228 included such virulence-associated proteins as PSMδ, autolysins (AtlE, 
Aae), and penicillin- and iron-binding proteins. ATCC12228 also seemed to produce more 
moonlighting proteins with adhesive and immunomodulatory functions, such as elongation 
factors EfTu, EfTs and EfG, enolase and chaperones (Kainulainen, Korhonen 2014). 
4.7 RP62A has the largest exoproteome (III)
Th e exoproteomes were studied by analyzing the culture supernatants of the three strains with 
GeLC-MS/MS (III). Th e identifi ed exoproteins (PM221: 451, ATCC12228: 395, RP62A: 518) were 
similarly distributed into clusters of orthologous groups (COG) (Tatusov, Natale et al. 2001) in all 
strains. Th e largest COG categories were translation, ribosomal structure and biogenesis (COG, 
J), followed by energy production and conversion (COG, C) and then carbohydrate, amino acid 
and nucleotide transport and metabolism (COG, G/E/F). Despite the overall similarities, there 
were more identifi ed proteins associated with cell wall/membrane/envelope biogenesis (COG, 
M) and post-translational modifi cation, protein turnover and chaperones (COG, O) in PM221 
and RP62A than in ATCC12228.
All proteins were classifi ed either as cytoplasmic or extracellular proteins on the basis 
of several prediction tools (PSORTb, SignalP, SecretomeP, TMHMM, PRED-LIPO, and 
ScanProsite) and manual inspection. Th e majority of the identifi ed proteins isolated from growth 
media were predicted to be cytoplasmic, comprising ~80% of all identifi cations (371, 313 and 415 
proteins in PM221, ATCC12228 and RP62A, respectively). Th e virulent RP62A strain produced 
the highest number of identifi able proteins that are primarily considered to be surface-attached 
and extracellular proteins (103; PM221, 80; ATCC12228, 82 proteins). Th ere were many proteins 
identifi ed with the classical N-terminal signal sequence for secretion i.e. 50 in PM221, 62 in 
ATCC12228 and 63 in RP62A. Also integral membrane proteins with transmembrane domains, 
lipoproteins with the characteristic lipobox motif, as well as proteins with the LPXTG motif 
mediating covalent anchoring to the cell wall, and the LysM motif which is known to be involved 




4.8 The exoproteomes of PM221 and RP62A are more similar to each 
other than to ATCC12228 (III)
Th ere were over 330 strain-shared identifi cations among the identifi ed exoproteins. Additionally, 
there were 48 (PM221), 22 (ATCC12228) and 98 (RP62A) proteins that were identifi ed from 
only one of the strains. Th ese included evolutionary unique proteins and proteins that were 
strain-shared but produced at an identifi able level only in one strain. In PM221, these specifi cally 
identifi ed proteins included proteins related to virulence such as glutamyl aminopeptidase, the 
ABC transporter OpuCA and methicillin-resistance associated proteins LytH, HmrA and FmhA. 
RP62A was the most effi  cient strain in exporting immunomodulatory antigens (IsaB), PSMα, 
adhesive proteins (SesE, SesG), and diff erent lipolytic, proteolytic and hydrolytic (Ure) enzymes. 
An in vitro urease activity test was conducted to determine how the identifi cation of urease (Ure), 
an important virulence factor, would be refl ected in the urease activity of the culture media. Th is 
assay confi rmed that the RP62A supernatant had the highest urease activity compared to the 
less virulent bovine and human strains, although ATCC12228 also exhibited a moderate level of 
urease activity. 
Th e comparison of exoproteomes revealed that the exoproteomes of PM221 and RP62A 
were more alike to each other than to ATCC12228. Th ere were also substantial diff erences in 
the identifi cation scores of the proteins that were identifi ed in all three strains. For example, 
β-lactamase (Bla), an enzyme that is involved in antibiotic resistance, was identifi ed in all 
strains, but with markedly higher scores in PM221 and RP62A as compared to ATCC12228. 
Th is indicated that the level of β-lactamase was higher in the supernatants of PM221 and RP62A, 
and this was verifi ed with an in vitro lactamase activity test. Th is test confi rmed that PM221 and 
RP62A supernatants had higher lactamase activity than ATCC12228, and it was concluded that 
Bla was being more effi  ciently exported by PM221 and RP62A under these test conditions.
Th e comparison between the exoproteome identifi cations (III) and the total proteome 
identifi cations (II) revealed that a large group of proteins were produced by both PM221 and 
ATCC12228 (II), but secreted out of the cell only by PM221 (III). Th ere was also a large group 
of proteins produced by both RP62A (III) and ATCC12228 (II), but which were secreted out of 
the cell by only RP62A. Th ese two groups were strongly overlapping indicating that PM221 and 
RP62A export similar proteins into the extracellular milieu.
4.9 SE is likely to use non-classical secre? on routes in protein export (III)
Several of the predicted cytoplasmic proteins that were identifi ed from the exoproteomes have 
been previously reported to be moonlighting proteins (Table 5) (Kainulainen, Korhonen 2014). 
For example, the glycolytic enzymes fructose-bisphosphate aldolase and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) have been postulated to function as intercellular signal 
molecules when they are attached outside the bacteria (Henderson, Martin 2013).
Results
30
Table 5. List of putative moonlighting proteins identifi ed in PM221 exoproteome.
Gene ID Protein
SEB00228 DNA-directed RNA polymerase beta subunit
SEB00312 Staphylococcal accessory regulator A
SEB00390 1-phosphofructokinase
SEB00430 Ribonucleotide reductase of class Ib (aerobic), alpha subunit
SEB00431 Ribonucleotide reductase of class Ib (aerobic), beta subunit
SEB00473 NAD-dependent glyceraldehyde-3-phosphate dehydrogenase
SEB00474 Phosphoglycerate kinase
SEB00475 Triosephosphate isomerase
SEB00476 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
SEB00477 Enolase
SEB00638 Glucose-6-phosphate isomerase
SEB00767 Pyruvate dehydrogenase E1 component alpha subunit
SEB00768 Pyruvate dehydrogenase E1 component beta subunit
SEB00769 Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex
SEB00770 Dihydrolipoamide dehydrogenase of pyruvate dehydrogenase complex
SEB00965 Glutamine synthetase type I
SEB01021 Low-specifi city L-threonine aldolase
SEB01260 Manganese superoxide dismutase; Superoxide dismutase [Fe]




SEB01643 Heat shock protein 60 family chaperone GroEL
SEB01734 Fructose-bisphosphate aldolase class II
SEB01747 Deoxyribose-phosphate aldolase
SEB02002 Phosphoglycerate mutase
SEB02159 Fructose-bisphosphate aldolase class I
SEB02347 Inosine-5’-monophosphate dehydrogenase
In addition to the moonlighting proteins displayed at the cell-surface, another type of non-
classical protein export of the cytoplasmic proteins could occur via membrane vesicles (MVs). 
Th is MV hypothesis was tested by fi ltering the culture supernatant through a membrane with 
100 kDa cutoff  and comparing the protein profi les of the control supernatant, retentate and fl ow-
through fractions using SDS-PAGE and SYPRO-Orange staining. Th e visualization revealed 
that the retentate contained proteins with a broad range of molecular masses, including low-
molecular mass (<100 kDa) proteins that would have been in the fl ow-through fraction if they 
had not been associated with larger structures such as MVs. Additionally, there was no overall 
enrichment of low-molecular-weight proteins in the fl ow-through fraction, which also implies 
that these small cytoplasmic proteins were being exported in high-molecular-weight structures. 
Th e major results of the three studies (I, II, II) are summarized in the Table 6.
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Table 6. Summary of the major results. Th e + and – represent the relative results and are not quantitative. 
N/A = not tested. Th e last row is a summary statement based on the overall estimation of the results.
PM221 ATCC12228 RP62A
Genome analysis (I) resembles 
ATCC12228
resembles PM221 more distant 
to PM221 and 
ATCC12228




forms a separate 
cluster
No. of surfacome proteins 
(moonlighting) (I)
+ ++  
Total proteome (II) similar to 
ATCC12228
similar to PM221  
Exoproteome (III) similar to RP62A diff ers from 
PM221 and RP62A
similar to PM221
Formation of SCVs (I) + + -
Catalase activity (I) + +++ ++
Biofi lm forming (II) + - ++
Tributyrin activity (II) ++ +  
Beta-lactamase activity (III) +++ ++ +++
Urease activity (III) + ++ +++
Non-classical secretion (III) ++ + ++
Experimental infection (I) ++ +  




Th e present thesis is composed of three published studies aiming to uncover the infectious and 
adaptive potentials of the SE species. Th e SE strains selected were isolated from bovine (IMI-
associated strain PM221) and human (the commensal-type and low-virulent ATCC12228 strain 
and the sepsis-associated strain RP62A) hosts. First, the genome sequence of the PM221 was 
defi ned and compared with the published and unpublished genome sequences of other SE and 
staphylococci (unpublished data). Th en proteomic approaches (2D DIGE and GeLC-MS/MS) 
were used on the diff erent cellular compartments to reveal the mechanisms contributing to 
virulence and adaptation as well as to complement the genome-level fi ndings. 
Th e genome-level analyses indicated that, while PM221 is very similar with the low-
infectious ATCC12228 strain, this bovine strain shares also some genetic factors (e.g. ACME 
element, genes for Aap, haemolysins, proteases and lipases) which are characteristics of the 
virulent SE strains (I). Th e results are in line with previous reports revealing that IMI-causing SE 
strains share the same genotype with human isolates and also produce the same virulence factors 
(Th orberg, Kuhn et al. 2006, Sawant, Gillespie et al. 2009, Jaglic, Michu et al. 2010, Piessens, Van 
Coillie et al. 2011). Th is supports the hypothesis that humans could be an important source of 
the bovine mastitis causing SE strains. Th e PM221 genome was also found to harbor the fdh 
(formate dehydrogenase) gene that is considered as a marker gene which can distinguish between 
non-pathogenic/commensal and pathogenic-type SE strains (Conlan, Mijares et al. 2012). Th ese 
fi ndings indicate that this marker gene may not be applicable for analyzing bovine-associated 
SE strains. Other distinctive features of the PM221 genome were the higher numbers of gene 
paralogs and prophage-type elements, which may have provided the bovine strain with better 
ability to survive and adapt within its bovine host. Another strain-specifi c feature was the aap 
gene coding for the accumulation associated protein (Rohde, Burdelski et al. 2005). Th is gene 
was carried by one of the plasmids in PM221, which could contribute to the adaptation- and 
biofi lm forming-capacity of PM221 as well as facilitate the transfer of this genetic feature to other 
strains.    
Th e 2D-DIGE analysis (I) that was used to confi rm the genome-level fi ndings demonstrated 
that the protein expression patterns of PM221 during the logarithmic and stationary phases of 
growth are more similar to those of the commensal strain ATCC12228. Th e 2DE-based proteomics 
suff ers from several limitations such as restricted dynamic range, diffi  culties in identifi cation of 
hydrophobic proteins as well as problems in resolving low abundance proteins with extreme 
pI and molecular weights (Gilmore, Washburn 2010). Th erefore, GeLC-MS/MS was used in 
surfacome (I), total proteome (II) and exoproteome (III) cataloging to maximize the number of 
protein identifi cations. Th is approach has proved to be eff ective in generating high-quality and 
near-to-complete protein catalogs of SA and other bacterial species (Becher, Hempel et al. 2009, 
Savijoki, Lietzen et al. 2011, Wolff , Hahne et al. 2008, Hempel, Pane-Farre et al. 2010, Beganovic, 
Guillot et al. 2010) as well as in discovering strain-specifi c marker proteins of closely related 
bacteria (Savijoki, Lietzen et al. 2011). Th e methods used were complementary. Th e 2D DIGE 
experiment (I) shed light on the proteome dynamics in diff erent growth phases and highlighted 
the similarities between the total proteomes of PM221 and ATCC12228. Th e use of GeLC-MS/
MS (I, II, III), in turn, substantially increased the number of identifi cations. It also elucidated the 
more virulent nature of PM221 and RP62A compared to ATCC12228, and indicated that PM221 
and RP62A are probably able to exploit non-classical secretion mechanisms more effi  ciently than 
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ATCC12228 in order to establish infections. Although the surfacome shaving experiment did 
not result in a large number of new identifi cations, this analysis indicated the surface-associated 
location of several proteins and showed that the commensal strain ATCC12228 presents more 
moonlighting proteins on the cell surface than the mastitis causing strain PM221. Additional 
comparative surfacome shaving analyses of several strains will still be needed before one could 
postulate that active moonlighting could be a general attribute of a commensal strain. 
A more detailed comparison of the protein expression patterns between the selected three 
strains further indicated that the bovine (PM221) and the commensal-type (ATCC12228) strains 
used less aggressive strategies to increase viability and persistence (e.g., down-regulation of the 
TCA cycle activity, increased formation of SCVs). Th e higher virulence capacity of RP62A was 
probably promoted by the increased expression of virulence and adaptation factors (coordinated 
by TF and CodY) and/or by producing persister cells in response to reactive oxygen species 
formed during the later stages of growth. Some SA strains have been shown to down-regulate 
the TCA cycle activity and to enhance the formation of SCVs as ways to improve persistence 
(Chatterjee, Herrmann et al. 2007, Chatterjee, Kriegeskorte et al. 2008, Chatterjee, Maisonneuve 
et al. 2011), and the SCV phenotype has recently been described in SE strains associated 
with prosthetic joint infections (Maduka-Ezeh, Greenwood-Quaintance et al. 2012, Bogut, 
Niedzwiadek et al. 2014). Since the proteomic analyses indicated that, in addition to PM221, 
also the ATCC12228 strain may be able to induce IMI, this hypothesis was tested in vivo using a 
bovine experimental infection model (I). Th e infection test demonstrated that the ATCC12228 
human strain was able to cause mastitis, albeit with milder clinical symptoms than those 
encountered with PM221. Th is ability to colonize and infect the bovine host might be partly 
explained by the large number of the adhesive moonlighting proteins identifi ed from the cell-
surface of ATCC12228. Also specifi c virulence factors (e.g. PSMδ, AtlE, Aae, SdrG, SspA/B) 
were found to be expressed by ATCC12228 despite its low-virulent phenotype (I, II). Th e more 
detailed comparison of the total proteome catalogs (II) and the identifi ed surfacomes of PM221 
and ATCC12228 revealed also diff erences with likely roles in virulence and/or adhesion. Th ese 
results suggested that PM221 would be more effi  cient in producing certain proteins involved in 
adherence, biofi lm formation (e.g. Aap), signal transduction, house-keeping functions, lipolysis 
(tributyrin cleaving activity) and/or immune evasion. Th e more pronounced production of 
lipolytic enzymes by PM221 was refl ected in the tributyrin cleavage test which revealed that 
PM221 was more active than ATCC12228 in cleaving this natural component of cow milk fat. 
In addition, the higher number of biofi lm-associated proteins from PM221 was refl ected in 
the adherent growth test demonstrating that the bovine strain was able to grow as a biofi lm 
in vitro. Both of these features could help the PM221 strain to adapt to the bovine host and 
to environments containing milk. On the other hand, the higher urease activity of the human 
strains may refl ect the diff erent ecological niches of these bacteria; ATCC12228 and RP62A 
live on human skin, on mucous membranes and on indwelling medical devices, which all are 
environments where the bacteria can come into contact with urea as part of body fl uids (Burne, 
Chen 2000). 
Th e total-proteome and surfacome cataloging were next complemented with exoproteome 
profi ling to identify all secreted virulence- and adaptation-associated factors (III). Th ese analyses 
revealed that RP62A possessed the largest exoproteome with the highest number of virulence-
related proteins. Both the RP62A and PM221 were more effi  cient in secreting β-lactamase, 
suggesting that these strains may have evolved this ability to deal with the β-lactam group of 
antibiotics, which they are likely to face during an infection. A notable fi nding was that PM221 
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and RP62A released a similar set of intracellular proteins into the surrounding environment. Th e 
same proteins were found to be synthesized by ATCC12228, but the present proteomic results 
indicated that these proteins are intracellular and/or are displayed at the cell-surface (I, II). Th ese 
fi ndings suggest that PM221 and RP62A export these cytoplasmic proteins out of the cell, which 
may be one of the bacterium’s strategies for enhancing virulence and adaptation. 
In numerous studies, large amounts of proteins that are theoretically predicted to be 
localized in the cytoplasm have been identifi ed on the surface or outside of the cell (Tjalsma, 
Lambooy et al. 2008, Dreisbach, Hempel et al. 2010, Solis, Larsen et al. 2010, Ythier, Resch et 
al. 2012). Th is was also the case in this study (III). It has been suggested that the concept of 
“subcellular location” should be revised so that it should be seen rather as dynamic traffi  cking 
between diff erent subcellular locations (Olaya-Abril, Jimenez-Munguia et al. 2013). Th us, 
instead of being described as cytosolic proteins found in the secretome or surfacome, these 
proteins could be termed “proteins for which algorithms of subcellular location predict to be in 
the cytoplasm, because lacking exporting/retention signals”, in other words as “non-classically 
secreted proteins” (Olaya-Abril, Jimenez-Munguia et al. 2013). 
How do the cytoplasmic proteins end up in the exoproteomes of the bovine and human SE 
strains? Th ree hypotheses off er plausible explanations, although these are not mutually exclusive. 
First, they might be in this location merely due to cell lysis (Tjalsma, Lambooy et al. 2008). 
In the present study, all three strains grew similarly in the growth media used, suggesting that 
there should not be any major diff erences in cell lysis susceptibilities between the strains. 
Second, they might be moonlighting proteins that have been exported to the cell-surface via 
some non-classical secretion route and then released during centrifugation or by some protease-
assisted mechanism e.g. as described for B. subtilis (Chhatwal 2002, Henderson, Martin 2011, 
Krishnappa, Dreisbach et al. 2013). Th e moonlighting proteins are secreted especially during the 
stationary growth phase, and at least for some of them protein domain structure modifi cations 
can contribute to this phenomenon (Yang, Ewis et al. 2011). Certain stress conditions favor 
the secretion of moonlighting proteins, for example high bile salt and glucose concentrations, 
elevated temperature and starvation, i.e. conditions that are thought to be part of the environment 
in which the bacteria live and that can aff ect the cell wall as well as membrane organization 
and permeability (Candela, Centanni et al. 2010, Saad, Urdaci et al. 2009, Wang, Xia et al. 2013, 
Kainulainen, Loimaranta et al. 2012). Aft er being exported, the secreted moonlighting proteins 
become attached to the cell surface. In gram-positive bacteria, this might be promoted by the 
negatively charged lipoteichoic acids of the cell envelope, and by the pH of the environment 
that can aff ect the net charge of moonlighting proteins (Kainulainen, Loimaranta et al. 2012, 
Antikainen, Kuparinen et al. 2007b). For example, ribosomal proteins are oft en found on the 
surface of bacteria – also on the surface of Gram-positive bacteria - as they have a particularly 
high affi  nity for the negatively charged cell wall (DebRoy, Dao et al. 2006, Severin, Nickbarg et 
al. 2007, Tjalsma, Lambooy et al. 2008, Pocsfalvi, Cacace et al. 2008, Resch, Leicht et al. 2006, 
Planchon, Chambon et al. 2007, Ruiz, Coute et al. 2009). In fact, they are so oft en found on 
the bacterial cell surfaces that they are considered as new anchorless surface proteins (DebRoy, 
Dao et al. 2006), and some of them have been demonstrated to be immunogenic in SA strains 
that cause human and bovine infections (Sinha, Kosalai et al. 2005, Geng, Zhu et al. 2008, Nho, 
Hikima et al. 2011). Also in the present study, over 45 ribosomal proteins were identifi ed in 
the exoproteomes of all three strains. Th e exoproteome samples were collected from the late-
logarithmic growth phase when the cells were already encountering environmental stresses. 
Th ese stresses are known to increase the release of moonlighting proteins in several bacteria 
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(Eichenbaum, Green et al. 1996, Ruiz, Coute et al. 2009, Kainulainen, Loimaranta et al. 2012), 
and this could serve as a partial explanation for the high number of identifi ed ribosomal and 
other moonlighting proteins. 
Another well-known moonlighting protein, the glycolytic enzyme enolase, was identifi ed 
in the growth media of all three strains and aft er surfacome shaving from both PM221 and 
ATCC12228 strains and in both growth conditions. Th e moonlighting, surface-associated 
enolase can act as a receptor for plasminogen leading to the proteolytic activity of plasminogen 
(Bhattacharya, Ploplis et al. 2012). Th is activity causes host matrix degradation and damage 
to connective tissue, and it has been observed to be present in several pathogenic bacteria 
(Nordstrand, Shamaei-Tousi et al. 2001, Sun, Ringdahl et al. 2004, Jonsson, Guo et al. 2004, 
Bhattacharya, Ploplis et al. 2012). Th ere are also reports that enolase can protect the bacterium 
from complement-mediated killing (Agarwal, Hammerschmidt et al. 2012). Other identifi ed 
adhesive and/or immunostimulatory enzymes observed in the exoproteomes included DnaK, 
GAPDH and Eft u, which were also found to be present in the surfacomes (I) of PM221 and 
ATCC12228. Th e moonlighting chaperone protein DnaK has been claimed to stimulate 
monocyte chemokine synthesis while glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has 
inhibited the H2O2 synthesis of human neutrophils (Wang, Kelly et al. 2001, Terao, Yamaguchi et 
al. 2006). Enolase, GAPDH and EfTu are also known to be antigenic (Ling, Feldman et al. 2004, 
Pancholi, Fischetti 1998, Granato, Bergonzelli et al. 2004). 
A third possible explanation for the extracellular location could be the export of those 
proteins via their incorporation inside MVs. Previous studies have demonstrated that SA 
MVs have distinct protein patterns and contain a high number of extracellular proteins with 
the protein and fatty acid compositions of MV-membrane diff ering from those on the plasma 
membrane (Kuehn, Kesty 2005, McBroom, Johnson et al. 2006, Rivera, Cordero et al. 2010). In 
the present study, the enrichment of the MV-fraction from culture supernatants (III) indicated 
that the small (<100 kDa) proteins had become embedded in larger structures, evidence 
that also SE – as SA – is able to use MVs as a way to secrete proteins in order to ensure full 
virulence. Th ese observations suggest that the MV-embedded proteins contain some specifi c 
sorting mechanism, and that the vesicles are not merely originating from dying cells, bacterial 
lysis or envelope instability. Th e MVs provide the bacteria with fl exibility in responding to the 
environmental changes and challenges, because the release of MVs is partly modulated by the 
ambient conditions such as availability of nutrients and the presence of antibiotics (Deatherage, 
Cookson 2012). Th ey have also a role in pathogenicity; for example SA has been shown to be able 
to deliver cytotoxic eff ector molecules into host cells via MVs both in vitro and in vivo (Gurung, 
Moon et al. 2011, Th ay, Wai et al. 2013). Taken together, the exoproteome results (III) revealed 
that SE can use diff erent non-classical secretion mechanisms – moonlighting and/or MVs – to 
enhance its adaptation and virulence.
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6 CONCLUSIONS AND FUTURE PERSPECTIVES
Th is study is the fi rst large-scale proteome analysis and the fi rst exoproteome analysis of the SE 
species. Th e diff erences and similarities between the bovine (PM221) and human (ATCC12228, 
RP62A) strains were elucidated, pinpointing potential strain-specifi c factors in virulence and 
adaptation, and confi rming the genome-level protein predictions. At the genome and total 
proteome levels, the bovine strain PM221 was found to be more similar to the low-virulent and 
commensal-type strain ATCC12228 than to the sepsis-associated strain RP62A. Both PM221 
and ATCC12228 were able to induce persistent IMI in an experimental bovine infection model, 
although the clinical outcome with the human strain was milder than that encountered with the 
bovine strain. Th ese fi ndings strengthen the hypothesis that humans could indeed be the source 
of bovine mastitis causing SE strains. 
In attempt to explain their full infectious potential, the exoproteomes of each three SE 
strains were compared. Th is comparison indicated that the exoproteome of PM221 resembled 
more that of RP62A than the exoproteome of ATCC12228. Th is fi nding together with the results 
demonstrating that PM221 and RP62A are more effi  cient in non-classical protein secretion, may 
explain the higher virulence capacity of PM221 than that of ATCC12228. Th ese studies also 
indicated that PM221 uses less aggressive strategies than RP62A when establishing an infection 
in vivo.
Although more phenotypic, immunological and mutational tests are needed to confi rm the 
biological and medical relevance of these results, they do represent the fi rst major large-scale 
proteomic characterization of this important pathogen, and identify potential candidates for 
future studies. Hopefully these results can serve as a stepping stone in the search for preventive 
and therapeutic solutions against staphylococcal infections. 
In future studies, the opportunistic nature of SE should be addressed; how the transition 
from commensalism to pathogenicity is refl ected in the proteome. To accomplish this, fi rst 
the genomes of several SE strains of both bovine and human origin should be sequenced. 
Th en, the predicted surfacome and exoprotome proteins should be compared in order to 
fi nd specifi c markers for commensalism and pathogenicity. Aft er this genome-level analysis, 
the eff ect of diff erent growth conditions on the expressed proteomes – especially surfacomes 
and exoproteomes - should be examined with proteomic approaches. Th ese diff erent growth 
conditions could include cultivation in growth media containing diff erent host-derived 
components, growth in bovine and human serum, growth in the presence of host cells, and/or 
cultivation with a variety of known stress factors such as changes in pH- and CO2-levels.  
Since this present study indicates that SE produces MVs, the biological relevance, protein 
composition, antigenicity, role in virulence and eff ects on the target cells of these secreted MVs 
should also be addressed. To accomplish this, the MVs of several SE strains should be visualized 
by electron microscopy, isolated, and the proteins embedded in MVs will need to be identifi ed. 
Th e major fi ndings would then be confi rmed with phenotypic tests, and the antigenicity of the 
identifi ed proteins should be evaluated with immunological methods. Th e adhesion and possible 
invasion to the target cells could, in turn, be studied with both human and bovine epithelial cell 
models. 
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